News and Events

Subscribe to our press distribution list to receive the latest news about AMW.

Upcoming

Events

No events available

Past

Events

Archive

Pharmapack

January 24-25, 2024 Paris, France https://www.pharmapackeurope.com/

Pharmasynergy

February 08-09, 2024
London, UK

euroPLX84

February 26-27, 2024 Lisbon, Portugal

BIO-Europe Spring

March 18-20, 2024
Barcelona, Spain
https://informaconnect.com/bioeurope-spring/

4th Wet AMD & Diabetic Eye Disease Drug Development

March 19-21, 2024
Boston, MA
https://wet-amd-drug-development.com/

BIO International Convention

June 03-06, 2024
San Diego, California
https://www.bio.org/events/bio-international-convention

CPHI South East Asia

July 10-12, 2024 Bangkok, Thailand https://www.cphi.com/sea/en/home.html

CPHI 2024

October 08-10, 2024 Milan, Italy https://www.cphi.com/europe/en/home.html

PODD – Partnership Opportunities in Drug Delivery

October 28-29, 2024 Boston, USA https://poddconference.com

BIO-Europe

November 04-06, 2024 Stockholm, Sweden https://informaconnect.com/bioeurope/

Latest

News

1. July 2024

AMW Appoints Additional Experts for Drug Delivery Systems to its Scientific Advisory Board

Warngau, Germany, July 1, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced the appointment of Prof. Miriam Breunig, Senior Academic Councillor at the University of Regensburg’s Department of Pharmaceutical Technology, and Prof. Karsten Mäder, Professor of Pharmaceutics at Martin Luther University Halle-Wittenberg, as members to AMW’s Scientific […]

3. June 2024

AMW Again Reports Record Financial Results 2023, CEO Philipp Karbach Becomes Shareholder, Investment Program For Employees Launched

Warngau, June 3, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today reported financial results for the year ended December 31, 2023. AMW posted a 2023 consolidated record revenue of EUR 29.4 million and achieved operating profitability for the second consecutive year. In addition, the Company reported a partial […]

15. May 2024

AMW Receives Notified Body Opinion by TÜV SÜD for its Leuprorelin Implant in Pre-Filled Syringe

Warngau, Germany, May 15, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that it has received the final report of the Notified Body Opinion (NBO) for its leuprorelin implant in pre-filled syringes. The NBO completes a diligent conformity review procedure by a notified body, in this case […]

11. April 2024

AMW welcomes Ilse Aigner, President of the Bavarian State Parliament, at the Warngau site to share a success story

Warngau, Germany, April 11, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, was delighted to welcome today the President of the Bavarian State Parliament, Ilse Aigner, to its headquarters in Warngau near Munich, Germany. In her speech to AMW employees, Ms. Aigner acknowledged the Company’s innovative strength and emphasized […]

9. January 2024

AMW Further Strengthens Executive Leadership Team by Appointing Dr. Joerg Serafimov as Chief Business Officer

Warngau, January 9, 2024 AMW GmbH, a specialty bio-pharmaceutical company focused on innovative sustained-release drug delivery systems, today announced that Dr. Joerg Serafimov has been appointed to the newly created role as Chief Business Officer (CBO), effective January 1, 2024. In this capacity, he is responsible for International Business and Licensing, Key Account Management, Business […]

For press and news inquiries please send an e-mail to news@a-m-w.eu